Fas ligand-mediated exocrinopathy resembling Sjogren's syndrome in mice transgenic for IL-10

被引:0
|
作者
Saito, I
Haruta, K
Shimuta, M
Inoue, H
Sakurai, H
Yamada, K
Ishimaru, N
Higashiyama, H
Sumida, T
Ishida, H
Suda, T
Noda, T
Hayashi, Y
Tsubota, K
机构
[1] Univ Tokushima, Sch Dent, Dept Pathol, Tokushima 770, Japan
[2] Tokyo Dent Coll, Dept Ophthalmol, Chiba, Japan
[3] Kaneka Co, Res Inst, Takasago Res Labs, Takasago, Hyogo, Japan
[4] Univ Tsukuba, Inst Clin Med, Dept Internal Med, Tsukuba, Ibaraki 305, Japan
[5] Natl Utano Hosp, Clin Res Ctr, Kyoto, Japan
[6] Osaka Biosci Inst, Dept Mol Biol, Osaka, Japan
[7] Inst Canc, Dept Cell Biol, Toshima Ku, Tokyo, Japan
来源
JOURNAL OF IMMUNOLOGY | 1999年 / 162卷 / 05期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Although IL-10 has been implicated in the pathogenesis of several autoimmune diseases, the mechanisms by which this cytokine mediates inflammatory lesions remain to be elucidated, Exocrine gland destruction is an important early step in the development of Sjogren's syndrome. To better understand the role of IL-10 in Sjogren's syndrome, we made transgenic mice in which the mouse IL-10 gene was regulated by the human salivary amylase promoter, Transgenic expression of IL-10 induced apoptosis of glandular tissue destruction and lymphocyte infiltration consisting primarily of Fas-ligand (FasL)(+) CD4(+) T cells, as well as in vitro upregulation of FasL expression on T cells, These data suggest that overexpression of IL-10 in the glands and their subsequent Fas/FasL-mediated bystander tissue destruction is a causal factor in the development of this disease.
引用
收藏
页码:2488 / 2494
页数:7
相关论文
共 50 条
  • [21] Inhibition of Fas Ligand in NOD Mice Unmasks a Protective Role for IL-10 against Insulitis Development
    Xiao, Zuoxiang
    Mohamood, Abdiaziz S.
    Uddin, Sophia
    Gutfreund, Rachel
    Nakata, Chiaki
    Marshall, Andrew
    Kimura, Hiroaki
    Caturegli, Patrizio
    Womer, Karl L.
    Huang, Yanfei
    Jie, Chunfa
    Chakravarti, Shukti
    Schneck, Jonathan P.
    Yagita, Hideo
    Hamad, Abdel Rahim A.
    AMERICAN JOURNAL OF PATHOLOGY, 2011, 179 (02): : 725 - 732
  • [22] IL-12 INHIBITS THE PRODUCTION OF IL-10 IN PATIENTS WITH SJOGREN SYNDROME
    Yao, G.
    Chen, W.
    Tang, X.
    Feng, X.
    Sun, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 950 - 950
  • [23] Dendritic cell function and its regulation by IL-10 in Sjogren's syndrome (SS).
    AlcocerVarela, J
    Segovia, DA
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 1051 - 1051
  • [24] Human chorionic gonadotropin prevents Sjogren's syndrome-like exocrinopathy in mice
    Li, Na
    Shigihara, Toshikatsu
    Tzioufas, Athanasios G.
    Notkins, Abner L.
    Yoon, Ji-Won
    Jun, Hee-Sook
    ARTHRITIS AND RHEUMATISM, 2007, 56 (07): : 2211 - 2215
  • [25] Caspase-1-independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice
    Tsutsui, H
    Kayagaki, N
    Kuida, K
    Nakano, H
    Hayashi, N
    Takeda, K
    Matsui, K
    Kashiwamura, S
    Hada, T
    Akira, S
    Yagita, H
    Okamura, H
    Nakanishi, K
    IMMUNITY, 1999, 11 (03) : 359 - 367
  • [26] The role of fas-fas ligand-mediated apoptosis in autoimmune lacrimal gland disease in MRL/MpJ mice
    Jabs, DA
    Lee, B
    Whittum-Hudson, J
    Prendergast, RA
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (02) : 399 - 401
  • [27] Fas and Fas ligand expression in the salivary glands of patients with primary Sjogren's syndrome
    Kong, LP
    Ogawa, N
    Nakabayashi, T
    Liu, GT
    DSouza, E
    McGuff, HS
    Guerrero, D
    Talal, N
    Dang, H
    ARTHRITIS AND RHEUMATISM, 1997, 40 (01): : 87 - 97
  • [28] Altered immune function in IL-10 transgenic mice.
    Hagenbaugh, A
    Sharma, S
    Aranda, R
    Cheroutre, H
    Moore, K
    Dubinett, S
    Kronenberg, M
    FASEB JOURNAL, 1996, 10 (06): : 1781 - 1781
  • [29] S-Nitrosylation of the Death Receptor Fas Promotes Fas Ligand-Mediated Apoptosis in Cancer Cells
    Leon-Bollotte, Lissbeth
    Subramaniam, Selvakumar
    Cauvard, Olivier
    Plenchette-Colas, Stephanie
    Paul, Catherine
    Godard, Cindy
    Martinez-Ruiz, Antonio
    Legembre, Patrick
    Jeannin, Jean-Francois
    Bettaieb, Ali
    GASTROENTEROLOGY, 2011, 140 (07) : 2009 - U242
  • [30] IL-10 promoter-1082 polymorphism is associated with elevated IL-10 levels in control subjects but does not explain elevated plasma IL-10 observed in Sjogren's syndrome in a Hungarian cohort
    Márka, M
    Bessenyei, B
    Zeher, M
    Semsei, I
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2005, 62 (05) : 474 - 480